Diagnos Laboratorium Utama Tbk. vs Xolare RCR Energy Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Xolare RCR Energy Tbk. trades at Rp103 (market cap 338.6B, 4.93M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Xolare RCR Energy Tbk. are close in size by market cap, and Xolare RCR Energy Tbk. is more actively traded (4.93M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SOLA | |
|---|---|---|
Market Cap | 310.75B | 338.6B |
Volume | 963.6K | 4.93M |
Lot | 9.64K | 49.33K |
Turnover | 217.67M | 510.04M |
Average Price | 225.89 | 103.39 |
Value | 217.67M | 510.04M |
Indicative Equilibrium Price | 226 | 103 |
Indicative Equilibrium Volume | 1K | 1.01K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Xolare RCR Energy (Formerly: PT RCR Energy Indonesia) (the "Company") was established based on Notarial Deed No. 213 dated December 18, 2014 drawn up before Notary Humberg Lie, S.H., S.E., M.Kn., in Jakarta. The ultimate beneficial owner of the Company is PT Energi Hijau Investama. The Company started its commercial activities in 2015.
Read more on SOLA →